# Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease

> **NCT06954311** · — · RECRUITING · sponsor: **Medical University Innsbruck** · enrollment: 120 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)
- IBD-unclassified (IBD-U)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06954311
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2030-02-17
- **Final completion:** 2030-02-17
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06954311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06954311, "Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06954311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*